Document Detail


Influence of ascites on tobramycin pharmacokinetics.
MedLine Citation:
PMID:  6707233     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The influence of ascites on the disposition of tobramycin was examined in eight subjects with cirrhosis of the liver. Five of these subjects had resolution of ascites so they could be used as their own controls. While there was no significant effect of ascites on the clearance and half-life of tobramycin, the volume of distribution of tobramycin was significantly larger when ascites was present, 0.32 versus 0.26 liter/kg (P less than 0.01). There was a trend for the volume of distribution to be larger in those patients with larger ascitic fluid volume.
Authors:
R Sampliner; D Perrier; R Powell; P Finley
Related Documents :
199903 - influence of methylcobalamin and cyanocobalamin on the neoplastic process in rats
6849873 - Fractionation and kinetic properties of rat liver and kidney methionine adenosyltransfe...
8819103 - Effects of dietary restriction on experimental gastric mucosal injury in fischer 344 rats.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of clinical pharmacology     Volume:  24     ISSN:  0091-2700     ISO Abbreviation:  J Clin Pharmacol     Publication Date:  1984 Jan 
Date Detail:
Created Date:  1984-05-17     Completed Date:  1984-05-17     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0366372     Medline TA:  J Clin Pharmacol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  43-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Ascites / metabolism*
Humans
Kinetics
Male
Middle Aged
Tobramycin / metabolism*
Chemical
Reg. No./Substance:
32986-56-4/Tobramycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analgesic efficacy after single and repeated doses of codeine and acetaminophen.
Next Document:  Pharmacokinetics of compound 58-112, a potential skeletal muscle relaxant, in man.